cagrilintide latest news VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes Novo Nordisk says compounded drugs
Novo Nordisk says compounded drugs are hurting Wegovy sales Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how CagrilintideSemaglutide in Adults with Overweight or Obesity and Type 2 Diabetes New England Journal of Medicine Cagrilintide: What It Is and How It's Being Studied for Weight Loss New in the August 14, 2025, issue of NEJM: CagrilintideSemaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) https: nej.md 444aW7f CagrilintideSemaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) https: nej.md 4ehQwLk
Pay in 4 interest-free payments of $7.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



